Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era

Currently, bone marrow (BM) biopsy (BMB) is recommended in the initial staging of patients with the presumed primary central nervous system (CNS) lymphoma (PCNSL). However, the added value of BMB in the era of positron emission tomography (PET-CT) has been challenged in other lymphoma subtypes. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelicic, Jelena, Hansen, Dennis Lund, Carlsen, Sarah Sand, Thorsgaard, Michael, Hersby, Ditte Stampe, Kannik, Karina, Munksgaard, Amalie Sofie Eilsø, Larsen, Thomas Stauffer, Juul-Jensen, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261253/
https://www.ncbi.nlm.nih.gov/pubmed/37246974
http://dx.doi.org/10.1007/s00277-023-05282-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261253/
https://www.ncbi.nlm.nih.gov/pubmed/37246974
http://dx.doi.org/10.1007/s00277-023-05282-7

Ejemplares similares